BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 19642876)

  • 1. Expression of the chemokine decoy receptor D6 is decreased in colon adenocarcinomas.
    Langenes V; Svensson H; Börjesson L; Gustavsson B; Bemark M; Sjöling Å; Quiding-Järbrink M
    Cancer Immunol Immunother; 2013 Nov; 62(11):1687-95. PubMed ID: 24013383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mechanism of chemokine receptor ACKR2 in cognitive impairment in young rats with traumatic brain injury.
    Quan L; Zhao Y; Ouyang C; Ying D; Xiong Z; Li X; Liao Z; Luo J; Liu H
    Am J Transl Res; 2023; 15(3):1654-1666. PubMed ID: 37056843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The scavenging chemokine receptor ACKR2 has a significant impact on acute mortality rate and early lesion development after traumatic brain injury.
    Woodcock TM; Frugier T; Nguyen TT; Semple BD; Bye N; Massara M; Savino B; Besio R; Sobacchi C; Locati M; Morganti-Kossmann MC
    PLoS One; 2017; 12(11):e0188305. PubMed ID: 29176798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal Protection by Genetic Deletion of the Atypical Chemokine Receptor ACKR2 in Diabetic OVE Mice.
    Zheng S; Coventry S; Cai L; Powell DW; Jala VR; Haribabu B; Epstein PN
    J Diabetes Res; 2016; 2016():5362506. PubMed ID: 26798651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The atypical chemokine receptor ACKR2 suppresses Th17 responses to protein autoantigens.
    Hansell CA; MacLellan LM; Oldham RS; Doonan J; Chapple KJ; Anderson EJ; Linington C; McInnes IB; Nibbs RJ; Goodyear CS
    Immunol Cell Biol; 2015 Feb; 93(2):167-76. PubMed ID: 25348934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of chemokines in hepatitis C virus-mediated liver disease.
    Brass A; Brenndörfer ED
    Int J Mol Sci; 2014 Mar; 15(3):4747-79. PubMed ID: 24646914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune regulation by atypical chemokine receptors.
    Nibbs RJ; Graham GJ
    Nat Rev Immunol; 2013 Nov; 13(11):815-29. PubMed ID: 24319779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. International Union of Basic and Clinical Pharmacology. [corrected]. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors.
    Bachelerie F; Ben-Baruch A; Burkhardt AM; Combadiere C; Farber JM; Graham GJ; Horuk R; Sparre-Ulrich AH; Locati M; Luster AD; Mantovani A; Matsushima K; Murphy PM; Nibbs R; Nomiyama H; Power CA; Proudfoot AE; Rosenkilde MM; Rot A; Sozzani S; Thelen M; Yoshie O; Zlotnik A
    Pharmacol Rev; 2014; 66(1):1-79. PubMed ID: 24218476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemokines, chemokine receptors and the gastrointestinal system.
    Miyazaki H; Takabe K; Yeudall WA
    World J Gastroenterol; 2013 May; 19(19):2847-63. PubMed ID: 23704819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of chemokines in acute liver injury.
    Saiman Y; Friedman SL
    Front Physiol; 2012; 3():213. PubMed ID: 22723782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocyte proliferation/growth arrest balance in the liver of mice during E. multilocularis infection: a coordinated 3-stage course.
    Zhang C; Wang J; Lü G; Li J; Lu X; Mantion G; Vuitton DA; Wen H; Lin R
    PLoS One; 2012; 7(1):e30127. PubMed ID: 22253905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypical chemokine receptors.
    Ulvmar MH; Hub E; Rot A
    Exp Cell Res; 2011 Mar; 317(5):556-68. PubMed ID: 21272574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DARC and D6: silent partners in chemokine regulation?
    Hansell CA; Hurson CE; Nibbs RJ
    Immunol Cell Biol; 2011 Feb; 89(2):197-206. PubMed ID: 21151196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional role of chemokines in liver disease models.
    Sahin H; Trautwein C; Wasmuth HE
    Nat Rev Gastroenterol Hepatol; 2010 Dec; 7(12):682-90. PubMed ID: 20975742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The chemokine scavenging receptor D6 limits acute toxic liver injury in vivo.
    Berres ML; Trautwein C; Zaldivar MM; Schmitz P; Pauels K; Lira SA; Tacke F; Wasmuth HE
    Biol Chem; 2009 Oct; 390(10):1039-45. PubMed ID: 19642876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The chemokine decoy receptor D6 prevents excessive inflammation and adverse ventricular remodeling after myocardial infarction.
    Cochain C; Auvynet C; Poupel L; Vilar J; Dumeau E; Richart A; Récalde A; Zouggari Y; Yin KY; Bruneval P; Renault G; Marchiol C; Bonnin P; Lévy B; Bonecchi R; Locati M; Combadière C; Silvestre JS
    Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2206-13. PubMed ID: 22796582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The lymphatic system controls intestinal inflammation and inflammation-associated Colon Cancer through the chemokine decoy receptor D6.
    Vetrano S; Borroni EM; Sarukhan A; Savino B; Bonecchi R; Correale C; Arena V; Fantini M; Roncalli M; Malesci A; Mantovani A; Locati M; Danese S
    Gut; 2010 Feb; 59(2):197-206. PubMed ID: 19846409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thromboxane A(2) receptor signaling promotes liver tissue repair after toxic injury through the enhancement of macrophage recruitment.
    Minamino T; Ito Y; Ohkubo H; Hosono K; Suzuki T; Sato T; Ae T; Shibuya A; Sakagami H; Narumiya S; Koizumi W; Majima M
    Toxicol Appl Pharmacol; 2012 Feb; 259(1):104-14. PubMed ID: 22206755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silent chemoattractant receptors: D6 as a decoy and scavenger receptor for inflammatory CC chemokines.
    Locati M; Torre YM; Galliera E; Bonecchi R; Bodduluri H; Vago G; Vecchi A; Mantovani A
    Cytokine Growth Factor Rev; 2005 Dec; 16(6):679-86. PubMed ID: 15996892
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.